Albert Ferro
Impact in
- Biochemistry top 0.5%
- Sulfur Compounds in Biology
- Eicosanoids and Hypertension Pharmacology
-
- Antiplatelet Therapy and Cardiovascular Diseases
- Renin-Angiotensin System Studies
Papers in
-
- Antiplatelet Therapy and Cardiovascular Diseases 24
- Blood Pressure and Hypertension Studies 11
- Renin-Angiotensin System Studies 7
- Physiology 36
- Nitric Oxide and Endothelin Effects 33
- Co-authors
- Christopher N. Floyd (11 shared papers)Gabriella Passacquale (17 shared papers)Yong Ji (24 shared papers)James M. Ritter (10 shared papers)Haitham H. Al‐Sa'doni (3 shared papers)Lindsay Queen (13 shared papers)Εugenia Gkaliagkousi (9 shared papers)Biao Xu (8 shared papers)
- Journals
- British Journal of Clinical Pharmacology (19 papers)British Journal of Pharmacology (10 papers)PLoS ONE (8 papers)Cardiovascular Research (7 papers)Atherosclerosis (5 papers)
- Partner nations
- United KingdomChinaUnited States
In The Last Decade
Albert Ferro
135 papers receiving 4.7k citations
Peers
Comparison fields: 5 of 147
- Biochemistry 588
- Cardiology and Cardiovascular Medicine 1.3k
- Internal Medicine 152
- Physiology 1.0k
- Clinical Biochemistry 189
Countries citing papers authored by Albert Ferro
This map shows the geographic impact of Albert Ferro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Albert Ferro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Albert Ferro more than expected).
Fields of papers citing papers by Albert Ferro
This network shows the impact of papers produced by Albert Ferro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Albert Ferro. The network helps show where Albert Ferro may publish in the future.
Co-authors
The 25 scholars most cited alongside Albert Ferro, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 137 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 286 | |
| 2 | 2003 | 210 | |
| 3 | 2000 | 163 | |
| 4 | 2003 | 156 | |
| 5 | 2011 | 156 | |
| 6 | 2008 | 145 | |
| 7 | 1999 | 142 | |
| 8 | 2007 | 134 | |
| 9 | 2013 | 124 | |
| 10 | 2014 | 110 | |
| 11 | 1993 | 106 | |
| 12 | 2015 | 99 | |
| 13 | 2013 | 93 | |
| 14 | 2015 | 82 | |
| 15 | 2002 | 79 | |
| 16 | 2004 | 69 | |
| 17 | 2000 | 68 | |
| 18 | 2010 | 66 | |
| 19 | 2009 | 64 | |
| 20 | 2009 | 61 |
About Albert Ferro
Albert Ferro is a scholar working on Cardiology and Cardiovascular Medicine, Physiology, Molecular Biology, Surgery and Endocrinology, Diabetes and Metabolism, having authored 137 papers that have together received 4.8k indexed citations. Recurring topics across this work include Nitric Oxide and Endothelin Effects (33 papers), Antiplatelet Therapy and Cardiovascular Diseases (24 papers), Blood Pressure and Hypertension Studies (11 papers), Lipoproteins and Cardiovascular Health (10 papers), Receptor Mechanisms and Signaling (8 papers), Angiogenesis and VEGF in Cancer (8 papers), Renin-Angiotensin System Studies (7 papers) and Hormonal Regulation and Hypertension (7 papers). The work is most often cited by research in Biochemistry (588 citations), Cardiology and Cardiovascular Medicine (1.3k citations), Internal Medicine (152 citations), Physiology (1.0k citations) and Clinical Biochemistry (189 citations). Albert Ferro has collaborated with scholars based in United Kingdom, China and United States. Frequent co-authors include Christopher N. Floyd, Gabriella Passacquale, Yong Ji, James M. Ritter, Haitham H. Al‐Sa'doni, Lindsay Queen, Εugenia Gkaliagkousi, Biao Xu, Pankaj Sharma and Liping Xie. Their work appears in journals such as British Journal of Clinical Pharmacology, British Journal of Pharmacology, PLoS ONE, Cardiovascular Research and Atherosclerosis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.